BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20490264)

  • 21. Overexpression of Gremlin-1 in patients with Loeys-Dietz syndrome: implications on pathophysiology and early disease detection.
    Wellbrock J; Sheikhzadeh S; Oliveira-Ferrer L; Stamm H; Hillebrand M; Keyser B; Klokow M; Vohwinkel G; Bonk V; Otto B; Streichert T; Balabanov S; Hagel C; Rybczynski M; Bentzien F; Bokemeyer C; von Kodolitsch Y; Fiedler W
    PLoS One; 2014; 9(8):e104742. PubMed ID: 25116393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
    Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
    Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
    Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
    Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel therapies emerging in oncology to target the TGF-β pathway.
    Kim BG; Malek E; Choi SH; Ignatz-Hoover JJ; Driscoll JJ
    J Hematol Oncol; 2021 Apr; 14(1):55. PubMed ID: 33823905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
    Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
    Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy.
    Zhao H; Wei J; Sun J
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107101. PubMed ID: 33099067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aneurysm syndromes caused by mutations in the TGF-beta receptor.
    Loeys BL; Schwarze U; Holm T; Callewaert BL; Thomas GH; Pannu H; De Backer JF; Oswald GL; Symoens S; Manouvrier S; Roberts AE; Faravelli F; Greco MA; Pyeritz RE; Milewicz DM; Coucke PJ; Cameron DE; Braverman AC; Byers PH; De Paepe AM; Dietz HC
    N Engl J Med; 2006 Aug; 355(8):788-98. PubMed ID: 16928994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
    Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
    BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta, cell signaling and cardiovascular disorders.
    Agrotis A; Kalinina N; Bobik A
    Curr Vasc Pharmacol; 2005 Jan; 3(1):55-61. PubMed ID: 15638782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta s stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts.
    Kay EP; Lee MS; Seong GJ; Lee YG
    Curr Eye Res; 1998 Mar; 17(3):286-93. PubMed ID: 9543637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β Signaling in Cancer.
    Syed V
    J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders.
    Bertolino P; Deckers M; Lebrin F; ten Dijke P
    Chest; 2005 Dec; 128(6 Suppl):585S-590S. PubMed ID: 16373850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-β Signaling.
    Wheeler JB; Ikonomidis JS; Jones JA
    Adv Exp Med Biol; 2021; 1348():161-184. PubMed ID: 34807419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines.
    Jacobsen SE; Ruscetti FW; Dubois CM; Lee J; Boone TC; Keller JR
    Blood; 1991 Apr; 77(8):1706-16. PubMed ID: 1707695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of TGF-β in Bone Metastases.
    Trivedi T; Pagnotti GM; Guise TA; Mohammad KS
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
    Gold LI; Sung JJ; Siebert JW; Longaker MT
    Am J Pathol; 1997 Jan; 150(1):209-22. PubMed ID: 9006337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells.
    Zhou S
    J Cell Biochem; 2011 Jun; 112(6):1651-60. PubMed ID: 21344492
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.